Neuroscience Therapy Corporation Receives Distribution Rights In Central And South America

LAS VEGAS, April 13 /PRNewswire-FirstCall/ - Neuroscience Therapy Corp. announced today that it now holds the exclusive distribution rights in Central and South America for its leading product P-Stim(TM), a patent protected medical device used to treat a variety of acute and chronic pain conditions.

Neuroscience plans to take advantage of the large Central and South American market worth billions of dollars. The Company believes its unique product P-Stim, will be able to take hold of a significant portion of this market, due to its efficacy and the fact that it has no known side effects.

Neuroscience President, Dr. Randolph A. Turpin said, “We’re very excited about this great opportunity. We’ve worked hard to get to this point and are ready to benefit from this multi-billion dollar market.”

About Neuroscience Therapy Corporation:

Neuroscience Therapy Corporation’s operations are located in Southern California. It holds the rights to a new, safe and innovative technology to relieve pain. Its product portfolio consists of two complimentary products: the P-Stim(TM) Electro Stimulation Device and the Multi-Point(TM) Stylus. These products have no known side effects, unlike many pharmaceutical pain relievers. The neurostimulation market is in its infancy and could reach several billion dollars in sales. The Company is working toward being a leader in this market. For more information about Neuroscience Therapy Corp., visit: www.neurosciencetherapy.com.

Legal Notice Regarding Forward Looking Statements

The statements in this press release that relate to the Company’s expectations with regard to the future impact on the Company’s results are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the Company’s actual results may differ materially from expected results.

Contact: Neuroscience Therapy Corporation Raymond Johnson 1-866-639-3900

Neuroscience Therapy Corporation

CONTACT: Neuroscience Therapy Corporation, Raymond Johnson, 1-866-639-3900

MORE ON THIS TOPIC